Goodwin Procter LLP advised OncoImmune on the deal. Baker Botts LLP advised Merck & Co. on the deal. OncoImmune announced its definitive agreement pursuant to which Merck…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
